Monsanto posted a higher-than-expected quarterly profit and raised its full-year forecast, but its shares fell more than 6 percent as Wall Street expressed disappointment that the company's results and outlook were not stronger.

The St. Louis-based agricultural products company, a global leader in the development of biotech crops, said revenue jumped 26 percent to a record $3.6 billion in the fiscal third quarter that ended May 31, though that fell shy of the average Wall Street estimate of $3.7 billion, according to Reuters Estimates.